GUELPH, ON, Oct 4 /CNW/ - BIOREM Inc. ("Biorem" or "the Company") (TSX-V: BRM) today announced that new orders totaling $2.4 million have been received since August 2010.
"We continue to consistently bring in orders from across our product portfolio in a competitive market environment," said Peter Bruijns, President and CEO. "To drive further growth, Biorem has invested in increased sales resources covering the international, renewable energy and industrial markets. The additional direct sales staff we added during this fiscal year have directly translated into an improved ability to open new markets as well as expand the geographical markets for our core odor products."
About BIOREM Inc.
Biorem is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency biological-based air emissions control systems. These systems are used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs), and for the conditioning of biogas renewable energy. With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 600 installed systems worldwide, Biorem not only offers state-of-the-art technology-based products but also peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This press release contains forward-looking statements based on current expectations. These forward-looking statements contain various risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the disclosure materials, financial statements and MD&A filed with the securities regulatory authorities in Canada on www.sedar.com
Non-GAAP Measures
"Order Bookings" and "Order Backlog" do not have any standardized meaning prescribed by Canadian generally accepted accounting principles ("GAAP") and may not be comparable to measures presented by other companies.
Order Bookings and Order Backlog are non-GAAP measures that the Company uses to evaluate its sales performance. Order Bookings are those binding contracts that the Company enters into with a third party for the delivery of our products or services. As Order Bookings are received, the contract value (before any associated sales taxes) is included in the Order Backlog. The Order Backlog is reduced by the revenue that is recognized on each project.
%SEDAR: 00020304E
For further information: For further information:
Peter Bruijns, President & CEO | James Smith, Investor Relations |
BIOREM Technologies Inc. | The Equicom Group Inc. |
[email protected] | [email protected] |
Tel: (519) 767-9100 x244 | Tel: (416) 815-0700 x229 |
Share this article